Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 20.78M 19.3M 17.75M 33.29M 2.29B 33.89M 231M 90.03M 1.12B 88.69M 86.77M 3.87B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 37.1M 34.47M 31.7M 59.45M 4.09B 60.51M 412M 161M 1.99B 158M 155M 6.91B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
04/08/17 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
15/05/17 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/02/17 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/11/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/10/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/05/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/02/16 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/02/16 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/12/15 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/12/15 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/12/15 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/11/15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/10/15 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 week+20.00%
Current month+2.44%
1 month+2.44%
6 months-17.65%
Current year+27.27%
1 week 0
Extreme 0.0035
0
1 month 0
Extreme 0.0035
0
Current year 0
Extreme 0.0016
0.01
1 year 0
Extreme 0.0016
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 0
0.02
10 years 0
Extreme 0
0.79
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+20.00%-36.36%+180.00% 1.33M
+7.45%-4.68%+22.65%+440.08% 2.13B
-2.14%-2.84% - - 1.87B
+2.84%-1.63%-39.67%-60.65% 1.65B
+3.08%-6.46%+83.69%+534.64% 1.31B
-1.41%-2.56%-47.16%+38.28% 1.2B
-0.59%-0.78%+317.74%+913.08% 1.08B
+2.82%+4.01%+54.18%+29.95% 977M
+2.81%-1.35%+19.82%+32.67% 696M
-2.38%-6.82%-45.48%-91.16% 407M
Average +1.23%-3.24%+36.60%+224.10% 1.13B
Weighted average by Cap. +1.91%-3.26%+45.09%+273.21%

Financials

2015 2016
Net sales 25.48M 22.41M 20.82M 19.15M 35.91M 2.47B 36.55M 249M 97.11M 1.2B 95.66M 93.59M 4.18B 32.33M 28.43M 26.41M 24.29M 45.56M 3.13B 46.38M 316M 123M 1.53B 121M 119M 5.3B
Net income 5.49M 4.83M 4.49M 4.13M 7.74M 532M 7.88M 53.68M 20.94M 260M 20.63M 20.18M 900M 2.06M 1.81M 1.68M 1.55M 2.9M 200M 2.96M 20.14M 7.86M 97.36M 7.74M 7.57M 338M
Net Debt 24.8M 21.82M 20.27M 18.64M 34.96M 2.4B 35.58M 242M 94.53M 1.17B 93.12M 91.11M 4.06B 18.56M 16.32M 15.16M 13.95M 26.16M 1.8B 26.62M 181M 70.73M 877M 69.68M 68.17M 3.04B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
346
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. AOXG Stock